CLINICAL_TRIALS
trial_result
· 2022-06-28
Clinical Trial Update: Benfotiamine in Alzheimer's Disease: A Pilot Study [Phase 2]
Summary
A Phase 2 pilot study assessing benfotiamine in Alzheimer's disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Burke Medical Research Institute | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2022-06-28